Pim Schreuder, Head and Neck Surgeon at Amsterdam UMC, shared on LinkedIn:
“An excellent PRO-Sarcoma meeting at the Connective Tissue Oncology Society (CTOS2026), brilliantly organised by Winette van der Graaf, Emily Holthuis, Tessa van Amerongen.
The meeting provided an opportunity not only to share the results of this exciting international collaborative project, which aims to give patients a voice and define how we measure quality of life in these rare cancers, but also to engage in valuable discussions about the next steps.
An important question is which aspects of quality of life are particularly relevant and unique to patients with sarcoma, considering the diversity in tumour location, histological subtype, age and disease status.
Perhaps even more importantly, how can we translate these insights into better, more personalised patient care? And how can we leverage these patient-reported outcomes in our dialogue with regulatory bodies to ensure that the care patients with these rare cancers need is appropriately recognised and reimbursed?
A big round of applause to Winette van der Graaf, Emily Holthuis, Tessa van Amerongen and all collaborators, including patient advocates, for bringing this important initiative forward!
Putting the patient’s voice at the centre of how we define and deliver care .”

You can also read:
Herbert Loong: PhD Candidate Hanfei Presents Leiomyosarcoma Research at CTOS 2026
Methotrexate for Osteosarcoma: Uses, Benefits and Side Effects